rs75143468

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001377.3(DYNC2H1):​c.10461A>G​(p.Gln3487Gln) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00265 in 1,594,474 control chromosomes in the GnomAD database, including 115 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 62 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 53 hom. )

Consequence

DYNC2H1
NM_001377.3 splice_region, synonymous

Scores

2
Splicing: ADA: 0.0004273
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.20
Variant links:
Genes affected
DYNC2H1 (HGNC:2962): (dynein cytoplasmic 2 heavy chain 1) This gene encodes a large cytoplasmic dynein protein that is involved in retrograde transport in the cilium and has a role in intraflagellar transport, a process required for ciliary/flagellar assembly. Mutations in this gene cause a heterogeneous spectrum of conditions related to altered primary cilium function and often involve polydactyly, abnormal skeletogenesis, and polycystic kidneys. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 11-103256240-A-G is Benign according to our data. Variant chr11-103256240-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 302091.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-103256240-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=3.2 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0146 (2227/152316) while in subpopulation AFR AF= 0.0506 (2102/41556). AF 95% confidence interval is 0.0488. There are 62 homozygotes in gnomad4. There are 1036 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 62 AR,Digenic gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DYNC2H1NM_001080463.2 linkc.10482A>G p.Gln3494Gln splice_region_variant, synonymous_variant Exon 69 of 90 ENST00000650373.2 NP_001073932.1 Q8NCM8-2
DYNC2H1NM_001377.3 linkc.10461A>G p.Gln3487Gln splice_region_variant, synonymous_variant Exon 68 of 89 ENST00000375735.7 NP_001368.2 Q8NCM8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DYNC2H1ENST00000650373.2 linkc.10482A>G p.Gln3494Gln splice_region_variant, synonymous_variant Exon 69 of 90 NM_001080463.2 ENSP00000497174.1 Q8NCM8-2
DYNC2H1ENST00000375735.7 linkc.10461A>G p.Gln3487Gln splice_region_variant, synonymous_variant Exon 68 of 89 1 NM_001377.3 ENSP00000364887.2 Q8NCM8-1
DYNC2H1ENST00000334267.11 linkc.2205+121821A>G intron_variant Intron 15 of 19 1 ENSP00000334021.7 Q8NCM8-3
ENSG00000285878ENST00000649070.1 linkn.691-3936T>C intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.0146
AC:
2226
AN:
152198
Hom.:
62
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00602
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00909
GnomAD3 exomes
AF:
0.00352
AC:
796
AN:
225988
Hom.:
28
AF XY:
0.00253
AC XY:
310
AN XY:
122322
show subpopulations
Gnomad AFR exome
AF:
0.0501
Gnomad AMR exome
AF:
0.00326
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000762
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000580
Gnomad OTH exome
AF:
0.000732
GnomAD4 exome
AF:
0.00139
AC:
1998
AN:
1442158
Hom.:
53
Cov.:
30
AF XY:
0.00121
AC XY:
869
AN XY:
716230
show subpopulations
Gnomad4 AFR exome
AF:
0.0487
Gnomad4 AMR exome
AF:
0.00372
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000147
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000525
Gnomad4 OTH exome
AF:
0.00308
GnomAD4 genome
AF:
0.0146
AC:
2227
AN:
152316
Hom.:
62
Cov.:
32
AF XY:
0.0139
AC XY:
1036
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.0506
Gnomad4 AMR
AF:
0.00601
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000206
Gnomad4 OTH
AF:
0.00900
Alfa
AF:
0.00249
Hom.:
12
Bravo
AF:
0.0167
Asia WGS
AF:
0.00347
AC:
12
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Asphyxiating thoracic dystrophy 3 Benign:3
Oct 16, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 07, 2022
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Jun 29, 2017
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jeune thoracic dystrophy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Short rib-polydactyly syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
6.9
DANN
Benign
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00043
dbscSNV1_RF
Benign
0.15
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs75143468; hg19: chr11-103126969; API